Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CenraTPE:3716 +0.14%25 Debt-to-Equity is 0.36 as of Jun. 2026, which is 10% below its 10-year median of 0.40. GuruFocus rates TPE:3716 with a GF Score™ of 25/100. The stock has 2 warning signs investors should review. Among 100 Medical Distribution companies, Cenra ranks better than 61% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Cenra's Debt-to-Equity or its related term are showing as below:
TPE:3716'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.33 Med: 0.4 Max: 0.46
Current: 0.36
During the past 5 years, the highest Debt-to-Equity Ratio of Cenra was 0.46. The lowest was 0.33. And the median was 0.40.
TPE:3716's Debt-to-Equity is ranked better than 61% of 100
companies
in the Medical Distribution industry
Industry Median: 0.465
vs TPE:3716: 0.36
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Cenra Debt-to-Equity Related Terms
Cenra Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Cenra's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:3716 vs MCK, COR, CAH: Debt-to-Equity Comparison
For the Medical Distribution subindustry, Cenra's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cenra Debt-to-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cenra's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Cenra's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cenra (TPE:3716) has a Debt-to-Equity of 0.36 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Cenra and its competitors. This is 10% below median its historical median of 0.40. Over the past decade, Cenra's Debt-to-Equity has ranged from 0.33 to 0.46. According to the industry distribution chart, Cenra ranks #39 out of 100 companies in the Medical Distribution industry, placing it in the top 39%.
Is Cenra's Debt-to-Equity too high?
Cenra's current Debt-to-Equity of 0.36 is 10% below median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 0.46. The Medical Distribution industry median Debt-to-Equity is 0.47. Cenra's value of 0.36 is 22.6% below this industry median. Based on the distribution chart, Cenra ranks #39 out of 100 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Cenra has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cenra's Debt-to-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Cenra ranks #39 out of 100 companies for Debt-to-Equity. This puts Cenra in the upper half of its industry. The industry median Debt-to-Equity is 0.47. Cenra's value of 0.36 is 22.6% below this benchmark. Historically, Cenra's own Debt-to-Equity has ranged from 0.33 to 0.46 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 0.47, Cenra has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Distribution company?
The median Debt-to-Equity among Medical Distribution companies is 0.47, based on 100 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cenra's current Debt-to-Equity of 0.36 is 22.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Cenra and its competitors. For the Medical Distribution industry, the median Debt-to-Equity is 0.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cenra's current Debt-to-Equity is 0.36, which is 10% below median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cenra stock overvalued right now?
Cenra (TPE:3716) has a current Debt-to-Equity of 0.36. The current Debt-to-Equity is 0.36, which is 10% below median its 10-year median of 0.40 and 22.6% below the Medical Distribution industry median of 0.47. Cenra's overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Cenra (TPE:3716), the current Debt-to-Equity is 0.36 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3716 has been successfully added to your 
